HUMIRA® (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars

Damon98701 Sep, 2021Health

Adalimumab was the first fully humanized, monoclonal antibody drug to be approved by the US FDA in 2002. The product was subsequently launched in 2003, and initially only indicated for the treatment of rheumatoid arthritis. In the succeeding years since its launch